Johese Clinical Research: Midstream

Pretoria, Gauteng 1692

0 studies enrolling now · 2 studies all time

What they study most

Candidemia, Candidiasis, Invasive, Dyslipidemia, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) — Completed